Cargando…
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
p53 messenger RNA expression was examined using a cDNA probe in 76 fresh primary breast tumour specimens, 15 of which came from patients treated with toxoxifen prior to surgery. A 2.8 kb mRNA for p53 was expressed in 43 of the 76 specimens. In 19 tumours the levels were similar to those seen in non-...
Autores principales: | Thompson, A. M., Steel, C. M., Chetty, U., Hawkins, R. A., Miller, W. R., Carter, D. C., Forrest, A. P., Evans, H. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971309/ https://www.ncbi.nlm.nih.gov/pubmed/2137009 |
Ejemplares similares
-
Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
por: Thompson, A. M., et al.
Publicado: (1998) -
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
por: Eccles, D. M., et al.
Publicado: (1992) -
Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
por: Munn, K. E., et al.
Publicado: (1996) -
pS2 is an independent factor of good prognosis in primary breast cancer.
por: Thompson, A. M., et al.
Publicado: (1993) -
Constitutional p53 mutation in a non-Li-Fraumeni cancer family.
por: Prosser, J., et al.
Publicado: (1992)